Literature DB >> 21129656

[Breast cancer with axillary lymph node involvement].

A Belaid1, S Kanoun, A Kallel, I Ghorbel, F Azoury, S Heymann, C Pichenot, R Verstraet, H Marsiglia, C Bourgier.   

Abstract

Breast cancer is the most frequent cancer of women in western countries. There are one million new cases per year in the world which represents 22% of all female cancers, and more than 370,000 deaths due to breast cancer per year (14% of cancer mortality). More than half of breast cancers are associated with axillary nodal involvement. Post-operative radiation therapy (XRT) is a crucial part of locoregional treatment in axillary nodal involvement breast cancer owing to a 15-years risk reduction of locoregional recurrence of 70% and to a 5.4% risk reduction of specific mortality. In 3D-conformal irradiation in such breast cancers, target volumes are chest wall when mastectomy was performed or breast and boost of tumor bed in case of breast conservative surgery, and supra-clavicular and/or axillary and/or internal mammary node areas. The main organs at risk are ipsilateral lung, heart and brachial plexus. The aim of this article is to describe epidemiologic, radio anatomic and prognostic features of axillary nodal involvement breast cancer and to propose guidelines for 3D-conformal treatment planning in locally advanced breast cancers. This review is illustrated by a case report.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21129656     DOI: 10.1016/S1278-3218(10)70017-2

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  3 in total

1.  Axillary metastasis from an occult tubal serous carcinoma in a patient with ipsilateral breast carcinoma: a potential diagnostic pitfall.

Authors:  Chantal Atallah; Gulbeyaz Altinel; Lili Fu; Jocelyne Arseneau; Atilla Omeroglu
Journal:  Case Rep Pathol       Date:  2014-07-09

2.  LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer.

Authors:  Fangfang Xu; Hui Li; Chengjiu Hu
Journal:  Biosci Rep       Date:  2019-07-08       Impact factor: 3.840

3.  [Triple negative breast cancer: clinical, pathological and molecular characteristics].

Authors:  Seifeddine Ben Hammouda; Nihed Abdessayed; Nouha Ben Abdeljelil; Hajer Hanchi; Dorra H Mida; Moncef Mokni
Journal:  Pan Afr Med J       Date:  2022-05-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.